The MCL-1 targeting effect of alvocidib potentiates the activity of cytarabine and mitoxantrone in a time-sequential regimen in AML

Autor: Kim, Wontak, Bahr, Brigham L., Soh, Katherine K., Bearss, Jeremiah J., Sol Lee, Ye, Peterson, Peter, Whatcott, Clifford J., Siddiqui-Jain, Adam, Weitman, Steven, Bearss, David J., Warner, Steven L.
Zdroj: In Clinical Lymphoma Myeloma and Leukemia September 2015 15 Supplement 2:S18-S18
Databáze: ScienceDirect